EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity

Marianna Menozzi, Maria Daria Di Trapani, Giulia Jole Burastero, Sara Volpi, Gianluca Cuomo, Maria Mazzitelli, Francesco Barbaro, Laura Labate, Anna Maria Cattelan, Antonio Di Biagio, Cristina Mussini

AIDS and Behavior · 2025

DOI: 10.1007/s10461-025-04736-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Marianna Menozzi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Infectious Diseases, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy. marymenozzi@gmail.com. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Modena e Reggio Emilia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pre-Exposure Prophylaxis (PrEP) with Tenofovir-Disoproxil/Emtricitabine (TDF/FTC) is efficacious for HIV prevention. PrEP users might be more exposed to other sexually transmitted infections (STIs) and toxicities. Our aim was to evaluate the trend of STIs and toxicities in an Italian PrEP cohort. A retrospective multicentre cohort study (Modena, Genova and Padova) including TDF/FTC-PrEP users followed from Jan-2019 to Jul-2022. Data collection included demographics, toxicities and STIs detection: N.gonorrhoeae (NG), C.trachomatis (CT), M.genitalium (MG), T.vaginalis (TV), T.pallidum (TP), HAV, HBV and HCV. Two-hundred-forty-four persons included: 97% males; median age 39 years (IQR 33–47). A nearly incremental trend was recorded in NG and MG incidences, especially after 2020: from 5.7% to 2.3% in 2020, to 10.3% and 6.5% in 2021 and to 9.6% and 4.8% in the first 7 months of 2022. CT and TP presented a variable trend, while only two TV diagnoses were done. The test for trend for ordered groups across years showed no statistical significance for all the STIs and the annual proportions of subjects with multiple STIs varied. At logistic regression, only history of STIs was associated to risk of new STIs. Twenty cases of nephrotoxicity were recorded, leading to PrEP interruption in 1 case only. Concluding, STIs incidence and nephrotoxicity in our cohort were consistent with other data from literature. In 2020 we observed a lower STIs incidence, probably as consequence of COVID-19 restrictions. An incremental trend could be hypothesized regarding NG, MG and CT incidence. Thus, we suggest STIs monitoring, prophylaxis and treatment to contain their spread among PrEP users.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisSexually Transmitted DiseasesHIV InfectionsAnti-HIV AgentsKidney DiseasesEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationHumansMaleItalyFemaleAdultRetrospective StudiesIncidenceMiddle AgedEmtricitabineTenofovir

Stichwörter der Autor:innen

AIDSHIVNephrotoxicityPrEPPreventionSTITenofovir/Emtricitabine

Substanzen

Anti-HIV AgentsEmtricitabineTenofovirEmtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Autor:innen und Institutionen

  • Clinic of Infectious Diseases, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy. marymenozzi@gmail.com.
  • Clinic of Infectious Diseases, University Hospital of Modena, University of Modena and Reggio Emilia, Modena, Italy.
  • Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.
  • Infectious Disease Clinic, Department of Health Sciences IRCCS Ospedale Policlinico San Martino, University of Genova, Genova, Italy.

Förderung

  • Università degli Studi di Modena e Reggio Emilia

Zitieren

APA

Menozzi, M., Trapani, M. D. D., Burastero, G. J., Volpi, S., Cuomo, G., Mazzitelli, M., Barbaro, F., Labate, L., Cattelan, A. M., Di Biagio, A., & Mussini, C. (2025). Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04736-5

Vancouver

Menozzi M, Trapani MDD, Burastero GJ, Volpi S, Cuomo G, Mazzitelli M, et al. Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity. AIDS and Behavior. 2025. doi:10.1007/s10461-025-04736-5

BibTeX
@article{Menozzi2025,
  author = {Menozzi, Marianna and Trapani, Maria Daria Di and Burastero, Giulia Jole and Volpi, Sara and Cuomo, Gianluca and Mazzitelli, Maria and Barbaro, Francesco and Labate, Laura and Cattelan, Anna Maria and Di Biagio, Antonio and Mussini, Cristina},
  title = {Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity},
  journal = {AIDS and Behavior},
  year = {2025},
  doi = {10.1007/s10461-025-04736-5}
}
Kostenlos starten →